Diabetes and other metabolic diseases drug discovery
Scotland has a world-class reputation for metabolic diseases research, with some of the finest diabetes researchers in the world based at Dundee University, while both Glasgow and Edinburgh universities are also involved in diabetes research
In addition, a number of companies are active in drug discovery and development intended for the treatment of diabetes and other metabolic diseases.
Metabolic diseases and diabetes expertise in Scotland
Dundee is the primary centre of excellence for diabetes research in Scotland, the ideal location to conduct clinical trials. Disease registers in diabetes, renal disease, stroke, child health, mental health and many others have grown from local initiatives into national databases, with obvious benefits for researchers.
The DARTS database includes data from some 150,000 diabetics across Scotland and information on diabetes care is linked to health records for studies of drug safety, epidemiology and patient management.
Some of the key researchers carrying out world-leading research into diabetes and other metabolic diseases in Scotland include
- Professor Grahame Hardie (University of Dundee).
- Professor Brian Frier (University of Edinburgh).
- Professor Sir Philip Cohen (University of Dundee).
- Professor Graeme Milligan (University of Glasgow).
- Professor Andrew Morris (University of Dundee).
- Professor Dario Alessi (University of Dundee).
Diabetes/metabolic diseases – Scottish universities and companies
The three Scottish universities carrying out research into diabetes and other metabolic diseases are:
The following companies are engaged in work to develop drugs to treat metabolic diseases, including diabetes:
Huge strides continue to be made in Scotland towards the better understanding and treatment of metabolic diseases, particularly diabetes. Contact SDI to learn more about the ways we can help your company invest in Scotland’s thriving diabetes/metabolic diseases drug development sector.